Nontuberculous mycobacterial (NTM) pulmonary disease (PD) is an emerging condition with heterogeneous manifestations from both the microbiological and the clinical point of view. Diagnostic and therapeutic guidelines are available but there are still unmet patients’ and physicians’ needs, including therapy-related adverse events, symptom control, management of comorbidities, risk of re-exposure to the pathogen and unfavourable outcomes. In the present review, we provide currently available evidence for an integrated approach to NTM-PD beyond antibiotic therapy. This includes 1) avoiding exposure to environments where mycobacteria are present and careful evaluation of lifestyle and habits; 2) implementing a personalised pulmonary rehabilitation plan and airway clearance techniques to improve symptoms, exercise capacity, health-related quality of life (QoL) and functional capacity in daily living activities; 3) a nutritional evaluation and intervention to improve health-related QoL and to control gastrointestinal side-effects during antimicrobial therapy, particularly in those with low body mass index and history of weight loss; and 4) managing comorbidities that affect disease outcomes, including structural lung diseases, immune status evaluation and psychological support when appropriate.

Faverio, P., De Giacomi, F., Bodini, B., Stainer, A., Fumagalli, A., Bini, F., et al. (2021). Non-tuberculous mycobacteria pulmonary disease: an integrated approach beyond antibiotics. ERJ OPEN RESEARCH, 7(2) [10.1183/23120541.00574-2020].

Non-tuberculous mycobacteria pulmonary disease: an integrated approach beyond antibiotics

Faverio, P
;
De Giacomi, F;Stainer, A;Luppi, F;Aliberti, S
2021

Abstract

Nontuberculous mycobacterial (NTM) pulmonary disease (PD) is an emerging condition with heterogeneous manifestations from both the microbiological and the clinical point of view. Diagnostic and therapeutic guidelines are available but there are still unmet patients’ and physicians’ needs, including therapy-related adverse events, symptom control, management of comorbidities, risk of re-exposure to the pathogen and unfavourable outcomes. In the present review, we provide currently available evidence for an integrated approach to NTM-PD beyond antibiotic therapy. This includes 1) avoiding exposure to environments where mycobacteria are present and careful evaluation of lifestyle and habits; 2) implementing a personalised pulmonary rehabilitation plan and airway clearance techniques to improve symptoms, exercise capacity, health-related quality of life (QoL) and functional capacity in daily living activities; 3) a nutritional evaluation and intervention to improve health-related QoL and to control gastrointestinal side-effects during antimicrobial therapy, particularly in those with low body mass index and history of weight loss; and 4) managing comorbidities that affect disease outcomes, including structural lung diseases, immune status evaluation and psychological support when appropriate.
Articolo in rivista - Review Essay
Non-tuberculous mycobacteria;
English
4-feb-2021
2021
7
2
00574-2020
open
Faverio, P., De Giacomi, F., Bodini, B., Stainer, A., Fumagalli, A., Bini, F., et al. (2021). Non-tuberculous mycobacteria pulmonary disease: an integrated approach beyond antibiotics. ERJ OPEN RESEARCH, 7(2) [10.1183/23120541.00574-2020].
File in questo prodotto:
File Dimensione Formato  
10281-300571_VoR.pdf

accesso aperto

Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Licenza: Creative Commons
Dimensione 686.86 kB
Formato Adobe PDF
686.86 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/300571
Citazioni
  • Scopus 22
  • ???jsp.display-item.citation.isi??? 19
Social impact